Stock Report

Bayer Diagnostics Ltd Open Offer Schedule revised



Posted On : 2007-04-02 22:51:32( TIMEZONE : IST )

Bayer Diagnostics Ltd Open Offer Schedule revised

JP Morgan India Pvt Ltd ("Manager to the Offer"), on behalf of Siemens AG ("Acquirer"), has issued this Corrigendum to the Public Announcement to the Shareholders of Bayer Diagnostics India Ltd ("Target Company"), which is in continuation of and should be read in conjunction with the Public Announcement ("PA") dated July 03, 2006, Corrigendum to the PA dated August 12, 2006 and Corrigendum to the PA dated March 24, 2007 and the Letter of Offer dated March 27, 2007, pursuant to and in compliance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and subsequent amendments thereto (the "Takeover Regulations"). The shareholders of the Target Company are required to note the following:

1. The Schedule of activates has been revised. The Revised Schedule of Activities should be read as follows:

------------------------------------------------------------------------------------------
Activity			Original Schedule		Revised Schedule
------------------------------------------------------------------------------------------
Specified Date 			July 07, 2006			July 07, 2006
Date of Opening of the Offer 	April 06, 2007			April 11, 2007
Date of Closing of the Offer	April 25, 2007			April 30, 2007
------------------------------------------------------------------------------------------

2. A total payment of Rs 668.94, comprising of Rs 629.45 as the Offer Price and Rs 39.49 as interest, computed at the rate of 10% per annum for the period from September 29, 2006, the original schedules date of payment of consideration to May 15, 2007, the revised scheduled date of payment of consideration (both days inclusive), will be thus made for each fully paid up equity share of the Target Company validity tendered and accepted under the Offer. Refer to the Letter of Offer for details on withholding taxes / tax to be deducted at source (TDS).

3. The other terms and conditions of the Offer remain unchanged.

Source : Equity Bulls

Keywords